Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Wednesday, October 28, 2020  Spokane, Washington  Est. May 19, 1883
Clear Night 35° Clear

Tag search results

Tags let us describe our content with keywords, making it easier to find what you're most interested in. Use the search box to look for tags, or explore our coverage with the lists below.


Washington sues Johnson & Johnson over opioids

Washington filed its third lawsuit tied to the opioid crisis Thursday, claiming one of the nation’s biggest companies deceived doctors and patients about the addictive nature of the painkillers it developed and marketed.

Deal encourages development of new overdose antidote spray

More companies could investigate the efficacy of using the drug nalmefene (used primarily in the management of alcohol dependence) as another easy-to-use opioid overdose antidote under a deal announced Thursday by New York’s attorney general.

Drugmakers, distributors face federal opioid probe

At least a half-dozen companies that make or distribute opioid painkillers are under a federal investigation of their role in a nationwide addiction and overdose crisis, according to a report.

Oklahoma judge reduces J&J order in opioid lawsuit by $107M

An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million to help address the state’s opioid crisis on Friday reduced that amount by $107 million in a final order he issued in the case.

Companies reach $260 million deal to settle opioids lawsuit

The nation’s three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday.

Judge will halt lawsuits against Purdue Pharma, its owners

A judge is pushing for a settlement of more than 2,600 lawsuits facing OxyContin maker Purdue Pharma with a decision Friday to pause litigation against the company and members of the wealthy Sackler family that owns the company.

State, local governments blast Purdue opioid settlement plan

Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma’s offer to settle thousands of lawsuits over the nation’s opioid crisis in court filings that also said the company had funneled up to $13 billion to its controlling family.

Purdue Pharma to stay in business as bankruptcy unfolds

A judge has cleared the way for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed over the opioid crisis. Purdue lawyers secured permission Tuesday for the company to maintain business as usual. That includes paying employees and vendors, supplying pills to distributors, and keeping current on taxes and insurance.